After a heady 2021, activity in European health care M&A is slowing down. Big ticket auctions have been withdrawn and processes are often run more cautiously as dual track, rather than general auctions. But underlying demand for health care assets is strong, with PE sitting on trillions of recently raised dry powder. Listed groups look cheap. HBI catches up with bankers from across Europe for their take.